JAG Growth Equity Thematic Insights: Q4 2024

December 2024 How to Invest in Concentrated Markets In our previous Insights pieces, we’ve explored key market themes, including the emergence of Generative AI and the growing impact of GLP-1 drugs on healthcare and consumer products. In this write-up, we will discuss a topic that has been garnering considerable attention – market returns being driven […]

JAG Fixed Income Thematic Insights: Q4 2024

December 2024 Summary Clients often ask us which corporate sectors, credit tiers, or tenors of the yield curve our team finds attractive. These are reasonable questions routinely addressed by fixed income managers. We tend to reframe the premise when asked ourselves. Rather than assigning outlooks to categorized segments, we prefer to identify those segments where […]

3rd Quarter 2024: Closing the Gap

Closing the Gap Stocks continued to advance in the third quarter, albeit with more volatility than experienced during the first half of 2024. Some of the market’s zigs and zags were driven by economic data, which appeared to be signaling a slowdown in the US economy. These concerns came to a head in early August, […]

JAG Growth Equity Thematic Insights: Q3 2024

September 2024 Summary We have extensively covered Gen AI developments in our previous Insights pieces and Q2 earnings season commentary was consistent with our expectations. Almost all of the world’s largest companies continue to prioritize AI infrastructure buildout. For example, Microsoft’s (MSFT) most recent quarterly capex was $19B and management noted that “cloud and AI-related […]

JAG Growth Equity Thematic Insights: Q2 2024

June 2024 Summary “Creative destruction” is a feature of capitalism and the modern global economy. The forces of innovation push society forward and ultimately result in better products and services for consumers. For investors, the rise of diabesity medications and Artificial Intelligence present opportunities as well as risks. Read more to learn how we are […]

1st Quarter 2024: Time Flies

Reflecting on 25 Years March 8th marked the 25th anniversary of my first day at JAG. In early 1999, my wife Chris and I had just turned 30 years old. Back then I thought I knew a fair amount about investing. More than two decades later, I realize that successful investing goes hand-in-hand with lifelong […]

JAG Team Insights — Q1 2024: Thematic Insights

April 2024 Summary Esteemed investor Howard Marks once said, “We may never know where we’re going, but we sure out to know where we are.” We agree with Mr. Marks. What follows is a brief overview of several of JAG’s Growth Portfolio Themes. Artificial Intelligence Secures Its Place GLP-1’s – A Disruptive Force in Medicine […]

4th Quarter 2023: A Catalyst-Driven Rally for Investors

Market Overview Stocks enjoyed a broad and powerful rally in the fourth quarter as the major US stock indices posted strong quarterly gains, including the 3rd-best combined November and December performance in the almost 100-year history of the S&P 500. After almost two years of hawkish Fed policy, investors have begun to project rate cuts […]

3rd Quarter 2021: Ch-ch-ch-changes

Firm Highlights Welcome Kate! Kate Hurt has joined JAG as Senior Vice President of Operations. Kate will work closely with JAG’s CEO and senior leadership to drive continued operational excellence throughout our firm. JAG’s new website will launch in early November. Please explore all the new information, enjoy the beautiful images, and share with your […]

Two Minute Insight: Timber! Could Inflation Fears be Calming Down?

Fears of higher inflation and interest rates have echoed through the capital markets for most of 2021. Although Fed Chairman Powell and most of his colleagues on the Federal Reserve Open Market Committee believe that recent inflationary pressures are “transitory,” the truth is that no one can be sure about the precise future path or […]

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

eMoney

eMoney is an industry-leading financial planning platform designed to help advisors, planners, and RIAs deliver personalized, comprehensive financial advice to clients across all stages of life.

Nitrogen

Nitrogen is a client-engagement and advisor platform built to bring clarity, quantification, and alignment to risk tolerance and portfolio construction. It uses a proprietary system that simplifies risk into a single, objective metric — the Risk Number® — allowing advisors and clients to speak the same language about risk, rather than relying on vague, subjective labels like “moderate” or “aggressive.”

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

You are now leaving

www.jagcap.com